SCHEMBL7147072

SCHEMBL7147072

Nc1nc(OC2CCCCC2)cc(-c2ccco2)n1

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CCNA2 P20248 1/20 0.45
CDK2 P24941 1/20 0.45
CCNA1 P78396 1/20 0.45
ADORA2A P29274 8/20 0.42
ADORA1 P30542 8/20 0.42
ADORA2B P29275 3/20 0.42
ADORA3 P0DMS8 2/20 0.42
ALDH1A1 P00352 2/20 0.40
LOX P28300 1/20 0.39
LOXL2 Q9Y4K0 1/20 0.39
MAPT P10636 2/20 0.39
HSD17B10 Q99714 1/20 0.39
SMARCA2 P51531 4/20 0.39
SMARCA4 P51532 4/20 0.39
PBRM1 Q86U86 4/20 0.39
NR1I2 O75469 1/20 0.39
KDM4E B2RXH2 1/20 0.38
BLM P54132 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30353576 0.76 ALDH1A1 (0.58) ADORA2AADORA1ADORA2BADORA3ALDH1A1
SCHEMBL1554000 0.75 MAPT (0.58) ADORA2AADORA1ADORA2BADORA3ALDH1A1
SCHEMBL7147906 0.73 MAPT (0.43) ADORA2AADORA1ADORA2BADORA3ALDH1A1
SCHEMBL7149233 0.72 CCNA2 (0.48) CCNA2CDK2CCNA1ADORA2AADORA1
SCHEMBL30108046 0.72 KDM4E (0.39) CCNA2CDK2CCNA1ADORA2AADORA1
SCHEMBL30108071 0.72 KDM4E (0.39) CCNA2CDK2CCNA1ADORA2AADORA1
SCHEMBL31403712 0.72 LOX (0.40) CDK2LOXLOXL2
SCHEMBL30488014 0.71 MAPT (0.53) ADORA2AADORA1ADORA2BADORA3ALDH1A1
SCHEMBL29044796 0.71 MAPT (0.53) ADORA2AADORA1ADORA2BADORA3ALDH1A1
SCHEMBL9341596 0.70 LOX (0.41) CDK2LOXLOXL2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6586441-B2 2-Amino-6-benzylsulfanyl-4-thiophen-2-yl-pyridine-3,5-dicarbo -nitrile as an examplary preferred compound; Alzheimer's and Parkinson's diseases; neuroprotectors; schizophrenia, analgesics; anxiolytic agents; respiratory disorders HOFFMAN-LA ROCHE INC. 2003-07-01 US disclosed